Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P. H. Clingen
-H2ax Foci Formation as a Pharmacodynamic Marker of DNA Damage Produced by DNA Cross-Linking Agents: Results From 2 Phase I Clinical Trials of SJG-136 (SG2000)
Clinical Cancer Research
Cancer Research
Oncology
Related publications
A Phase I Trial of SJG-136 (NSC#694501) in Advanced Solid Tumors
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
MicroRNA-138 Modulates DNA Damage Response by Repressing Histone H2AX Expression
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Inhibition of the Nedd8 System Sensitizes Cells to DNA Interstrand Cross-Linking Agents
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Telomeric DNA Damage by Topoisomerase I
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
DNA Damage-Processing Pathways Involved in the Eukaryotic Cellular Response to Anticancer DNA Cross-Linking Drugs
Molecular Pharmacology
Molecular Medicine
Pharmacology
Characterization of DNA Repair Foci in Root Cells of Arabidopsis in Response to DNA Damage
Frontiers in Plant Science
Plant Science
Linking DNA Damage, NAD+/SIRT1, and Aging
Cell Metabolism
Cell Biology
Molecular Biology
Physiology
ZNF506-dependent Positive Feedback Loop Regulates H2AX Signaling After DNA Damage
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Early Models of DNA Damage Formation
Journal of Physics: Conference Series
Astronomy
Physics
